David Wexler to Canagliflozin
This is a "connection" page, showing publications David Wexler has written about Canagliflozin.
Connection Strength
0.118
-
Devineni D, Curtin CR, Marbury TC, Smith W, Vaccaro N, Wexler D, Vandebosch A, Rusch S, Stieltjes H, Wajs E. Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor. Clin Ther. 2015 Mar 01; 37(3):610-628.e4.
Score: 0.118